abagovomab 33
abciximab 29
abituzumab 20
abrilumab 19
actoxumab 16
adalimumab 17
aducanumab 10
afasevikumab 17
alacizumab_pegol 14
alemtuzumab 24
alirocumab 21
amatuximab 38
andecaliximab 20
anifrolumab 21
anrukinzumab 18
aprutumab 14
aprutumab_ixadotin 14
arcitumomab 24
ascrinvacumab 7
atezolizumab 15
atinumab 14
avelumab 13
basiliximab 30
bavituximab 36
begelomab 25
benralizumab 25
bevacizumab_beta 23
bezlotoxumab 16
bimagrumab 12
bleselumab 17
blinatumomab 35
blosozumab 28
bococizumab 17
brazikumab 15
brentuximab_vedotin 26
briakinumab 16
brodalumab 12
brolucizumab 27
brontictuzumab 24
burosumab 17
cabiralizumab 24
camrelizumab 14
canakinumab 26
cantuzumab_ravtansin 45
carlumab 15
carotuximab 29
cergutuzumab_amunaleukin2 25
cergutuzumab_amunaleukin 25
certolizumab_pegol 24
cetiximab 44
citatuzumab_bogatox 26
cixutumumab 25
clivatuzumab_tetraxetan 21
codrituzumab 32
conatumumab 10
concizumab 32
crenezumab 21
crizanlizumab 23
crotedumab 20
dacetuzumab 21
daclizumab 16
dalotuzumab 36
dapirolizumab_pegol 25
daratumumab 14
dectrekumab 9
demcizumab 24
denosumab 11
depatuxizumab 21
depatuxizumab_mafodotin 21
dezamizumab 18
dinutuximab 36
diridavumab 15
domagrozumab 15
drozitumab 17
duligotuzumab 19
durvalumab 10
dusigitumab 11
efalizumab 29
efungumab 30
eldelumab 14
elezanumab 17
elgemtumab 12
elotuzumab 16
emactuzumab 18
emapalumab 25
emibetuzumab 16
enavatuzumab 24
enfortumab_vedotin 12
enoblituzumab 16
enokizumab 22
enoticumab 17
ensituximab 32
eptinezumab 17
erenumab 17
etaracizumab 18
etrolizumab 22
evinacumab 21
evolocumab 16
farletuzumab 14
fasinumab 21
fezakinumab 15
fibatuzumab 9
ficlatuzumab 21
firivumab 33
flanvotumab 17
fletikumab 23
foralumab 13
foravirumab 12
fremanezumab 28
fresolimumab 17
fulranumab 20
futuximab 28
galcanezumab 21
ganitumab 27
gantenerumab 11
gemetuzumab 26
gemtuzumab2 25
gemtuzumab 25
gevokizumab 23
girentuximab 35
glembatumumab 16
glembatumumab_vedotin 16
guselkumab 20
ibalizumab 28
ibritumomab 32
icrucumab 8
idarucizumab 35
ifabotuzumab 9
imalumab 17
imgatuzumab 19
inclacumab 17
indatuximab_ravtansin 34
indusatumab 16
inebilizumab 30
intetumumab 14
iodine_girentuximab 28
ipilimumab 3
iratumumab 12
isatuximab 36
itolizumab 24
ixekizumab 33
labetuzumab_govitecan 24
lambrolizumab 26
lampalizumab 24
lanadelumab 17
landogrozumab 17
laprituximab 25
lebrikizumab 36
lendalizumab 22
lenzilumab 14
lifastuzumab_vedotin 25
ligelizumab 22
lilotomab 37
lirilumab 21
lodelcizumab 16
lokivetmab 26
lorvotuzumab_mertansin 27
lucatumumab 27
lumretuzumab 18
lupartumab 10
lutikizumab 21
margetuximab 35
milatuzumab 40
mirvetuximab 35
mirvetuximab_soravtansin 35
modotuximab 36
mogamulizumab 36
monalizumab 16
motavizumab 29
moxetumomab_pasudotox 32
namilumab 16
naratuximab 24
naratuximab_emtansin 24
narnatumab 15
navicixizumab2 29
navicixizumab 25
navivumab 34
necitumumab 10
nemolizumab 24
nesvacumab 14
nivolumab 14
obiltoxaximab 23
obinutuzumab 37
ocaratuzumab 25
ofatumumab 18
olaratumab 19
olokizumab 26
omalizumab 20
onartuzumab 21
ontuxizumab 26
opicinumab 14
orticumab 13
otelixizumab 37
oxelumab 12
ozanezumab 29
pamrevlumab 11
panobacumab 29
parsatuzumab 25
pasotuxizumab 20
pateclizumab 14
patritumab 19
pembrolizumab 26
perakizumab 22
pidilizumab 18
pinatuzumab_vedotin 18
plozalizumab 35
pogalizumab 22
polatuzumab_vedotin 20
ponezumab 38
prezalumab 12
pritoxaximab 37
quilizumab 21
racotumomab 27
radretumab 14
ralpancizumab 21
ramucirumab 14
ranevetmab 27
ranibizumab 23
refanezumab 28
remtolumab 18
rilotumumab 17
rinucumab 18
risankizumab 35
rituximab 20
rivabazumab 17
robatumumab 20
roledumab 28
romosozumab 21
rontalizumab 19
rosmantuzumab 20
rozanolixizumab 22
sacituzumab 27
sacituzumab_govitecan 27
samalizumab 24
sapelizumab 23
sarilumab 17
secukinumab 14
seribantumab 17
setoxaximab 44
sifalimumab 10
siltuximab 27
simtuzumab 26
sirukumab 12
solanezumab 25
solitomab 30
stamulumab 19
suptavumab 22
suvizumab 19
tabalumab 14
tadocizumab 14
tamtuvetmab 33
tanezumab 21
tarextumab 11
tavolixizumab 17
telisotuzumab 25
teplizumab 20
tesidolumab 19
tezepelumab 23
tigatuzumab 17
tildrakizumab 18
timolumab 15
tisotumab 13
tosatoxumab 34
tositumomab 32
tralokinumab 27
trastuzumab 22
tregalizumab 33
trevogrumab 13
ublituximab 30
urelumab 17
ustekinumab 25
utomilumab 27
vadastuximab 22
vadastuximab_talirin 22
vandortuzumab_vedotin 16
vantictumab 20
vanucizumab2 23
vanucizumab 28
varlilumab 12
vatelizumab 20
vedolizumab 27
veltuzumab 15
vesencumab 13
vorsetuzumab 21
vorsetuzumab_mafodotin 21
vunakizumab 33
xentuzumab 16
zatuximab 36
